In fact, this has been evidenced by numerous studies reporting an increased incidence of breast, ovarian, pancreatic, or prostate cancer tightly associated with the heterozygosity of several FA genes (FANCD1, FANCJ, FANCN, FANCO or/and FANCS) [22, 46-57]. The gene discussed is BRCA2; the disease is prostate carcinoma.